U-48800
Overview[edit | edit source]
U-48800 is a synthetic opioid analgesic that is structurally related to U-47700, a compound that was originally developed in the 1970s by the pharmaceutical company Upjohn. U-48800 is part of a class of drugs known as the benzamide opioids, which are known for their potent analgesic effects.
Chemical Structure[edit | edit source]
U-48800 has a chemical structure that is similar to other opioids in the benzamide class. The structure consists of a benzene ring attached to an amide group, with various substitutions that influence its pharmacological properties. The specific arrangement of atoms in U-48800 contributes to its high affinity for the mu-opioid receptor, which is responsible for its analgesic effects.
Pharmacology[edit | edit source]
U-48800 acts primarily as a mu-opioid receptor agonist, which means it binds to and activates these receptors in the central nervous system. This action results in the inhibition of pain signals, leading to analgesia. Like other opioids, U-48800 can also produce euphoria, sedation, and respiratory depression.
Effects and Risks[edit | edit source]
The effects of U-48800 are similar to those of other potent opioids. Users may experience intense euphoria and pain relief, but these effects are accompanied by significant risks. The primary dangers associated with U-48800 use include respiratory depression, which can be fatal, and the potential for addiction and tolerance.
Legal Status[edit | edit source]
Due to its potential for abuse and lack of medical use, U-48800 is classified as a controlled substance in many jurisdictions. The legal status of U-48800 varies by country, with some nations having specific regulations against its manufacture, distribution, and possession.
Related Compounds[edit | edit source]
U-48800 is chemically related to several other synthetic opioids, including U-47700, U-49900, and AH-7921. These compounds share similar structures and pharmacological profiles, contributing to their classification as designer drugs.
Related pages[edit | edit source]
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD
